Vertex Pharmaceuticals · Health Care
VRTX
$485.65
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.福泰制药公司是一家总部位于马萨诸塞州波士顿的美国生物制药公司，是最早采用理性药物设计（而非组合化学）明确策略的生物技术公司之一。
Mixed profile混合特征
Large cap大盘
$123B
Engine stance引擎立场2026-07-20
Neutral — no clear edge中性 — 无明显优势
Setup almost complete — likely buy trigger in ~1–3 trading days if it closes back above its 10-day average.形态接近完成——若收盘重新站上 10 日均线，预计将在约 1–3 个交易日内出现买入触发。
Price Chart价格图表
Key Statistics关键统计
Price价格
$485.65
8.3% below 52-week high低于52周高点 8.3%
Market Cap市值
$123B
Normal volume正常成交量
P/E Ratio市盈率
31.2x
28.9x sector median
Forward P/E预测市盈率
22.7x
EPS每股收益 $15.56
Beta贝塔
0.59
Moves about 0.6x the market波动幅度约为市场的 0.6 倍
RSI (14)RSI（14）
53
Neutral zone中性区域
Next Earnings下次财报
2026-08-03 (15d)
Volatility Rank波动率分位
81th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
1.9% of float
Performance价格表现
| Period周期 | VRTX | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +0.1% | -1.5% | Beat the index by 1.6 points跑赢指数 1.6 个百分点 |
| 1 Month近1月 | +5.8% | +0.6% | Beat the index by 5.2 points跑赢指数 5.2 个百分点 |
| 3 Months近3月 | +10.1% | +4.7% | Beat the index by 5.4 points跑赢指数 5.4 个百分点 |
| 6 Months近6月 | +10.0% | +7.8% | Beat the index by 2.2 points跑赢指数 2.2 个百分点 |
| Year to date年初至今 | +7.4% | +9.1% | Lagged the index by 1.7 points落后指数 1.7 个百分点 |
| 1 Year近1年 | +4.8% | +19.4% | Lagged the index by 14.6 points落后指数 14.6 个百分点 |
| 3 Years近3年 | +35.3% | +69.4% | Lagged the index by 34.1 points落后指数 34.1 个百分点 |
| 5 Years近5年 | +140.1% | +83.9% | Beat the index by 56.2 points跑赢指数 56.2 个百分点 |
Technicals技术面
Active signals活跃信号
1-Day Return (cross-sectional rank → top/bottom gainers)Valuation cheapness percentile (0–1, higher = cheaper vs peers)Insider Power (0–100) — quality-weighted Form-4 open-market trades (role × size × recency); 50 = neutralInsider Sell signal — fires when Insider Power ≤ 40 (net selling on quality-weighted basis)Ichimoku — Price Above Cloud
RSI (14)RSI（14）
53
Neutral zone中性区域
vs 50-day相对50日均线
+5.6% vs 50-day avg
vs 200-day相对200日均线
+8.1% vs 200-day avg
Trend strength (ADX)趋势强度（ADX）
28
Trending趋势中
Volatility rank波动率分位
81th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$480.05
Don't chase above不追高于
$490.10
Stop止损
$444.90
Buy soon — on confirmation即将买入 — 待确认
Earnings财务业绩
15
days until next report天后公布财报
2026-08-03
Estimates being cut预期下调
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | VRTX | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 31.20x | 28.92 | 44% |
| P/E (forward)市盈率（预测） | 22.7x | — | — |
| P/B市净率 | 6.61x | 3.52 | 23% |
| P/S市销率 | 10.28x | 3.02 | 10% |
| Earnings yield盈利收益率 | 3.20% | 2.72 | 59% |
| FCF yield自由现金流收益率 | 2.59% | 3.94 | 30% |
| Shareholder yield股东收益率 | 1.64% | 1.89 | 44% |
| EV/EBITDA企业价值/EBITDA | 26.98x | 18.21 | 26% |
| P/FCF市值/自由现金流 | 38.62x | 22.42 | 19% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 14.1%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 8.3%
Free Cash Flow自由现金流
Margins利润率
21.2%Return on Equity股本回报率
15.4%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -1.16 |
| Current ratio流动比率 | 2.90 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $2.0B |
| Stock-based comp股权薪酬 | $685.9M |
| Share count change (1y)股数变化（1年） | -1.1% |
Piotroski皮奥特罗斯基 6/8
Altman Z阿尔特曼Z: safe (12.7)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 27% of its sector on blended multiples综合估值倍数低于行业内 27% 的公司
Beta市场敏感度
0.59×
0.21×3×
Moves about 0.6× the market波动幅度约为市场的 0.6 倍
Financial Health财务健康
6/8
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Sector / Theme行业/主题
Big Pharma theme — #3 of 46 themes「大型药企」主题 — 46 个主题中第 3 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
VRTX daily MACD crossed downVRTX 日线MACD下穿
Options Positioning期权持仓
Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.37%
Expected weekly move预期周波动
±5.30%
Call wall看涨密集区
$500
Put wall看跌密集区
$430
Gamma flip伽玛翻转
$460
25d risk reversal25d风险逆转
-4.1%
Skew: 偏斜：fear
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$146.9M net (0 buyers, 13 sellers)-$146.9M 净值（0 买家，13 卖家）
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 10, 2026
VRTX daily MACD crossed downVRTX 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $485.39.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$485.39。
Jul 2, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jul 2, 2026
VRTX took relative-strength leadershipVRTX 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $528.04.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$528.04。
Jul 2, 2026
VRTX made a new 52-week highVRTX 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $528.04.价格创出52周新高 — 全市场关注的动量/趋势极值。$528.04。
Jul 1, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有
Jun 30, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jun 29, 2026
Golden cross on VRTXVRTX 金叉
The 50-day average crossed above the 200-day — a slow, widely-watched bullish trend signal. $499.65.50日均线上穿200日均线 — 一个滞后但广受关注的看多趋势信号。$499.65。
Jun 29, 2026
VRTX made a new 52-week highVRTX 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $499.65.价格创出52周新高 — 全市场关注的动量/趋势极值。$499.65。
Jun 26, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jun 26, 2026
VRTX RSI reached overboughtVRTX RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $491.34.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$491.34。
Jun 22, 2026
BOTTOMING → UPTREND筑底中 → 上涨趋势
HOLD持有
Showing last 15 of显示最近15条，共 3010 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.46
Value价值
-0.8
Quality质量
-0.8
Investment资本投入
-0.3
Shareholder payout股东回报
-0.6
Low volatility低波动
+0.2
Low market beta低市场敏感度
+0.3
Earnings quality盈利质量
-1.0
Short interest空头兴趣
+1.1
Company Profile公司档案
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.福泰制药公司是一家总部位于马萨诸塞州波士顿的美国生物制药公司，是最早采用理性药物设计（而非组合化学）明确策略的生物技术公司之一。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Receivables stretch
- Inventory build
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。